RIHAWI, KARIM
 Distribuzione geografica
Continente #
NA - Nord America 735
EU - Europa 646
AS - Asia 360
AF - Africa 53
Totale 1.794
Nazione #
US - Stati Uniti d'America 732
IT - Italia 283
CN - Cina 142
SG - Singapore 97
GB - Regno Unito 84
VN - Vietnam 69
DE - Germania 68
SE - Svezia 64
IE - Irlanda 39
IN - India 28
TG - Togo 27
RU - Federazione Russa 20
BG - Bulgaria 18
CH - Svizzera 15
FR - Francia 15
CI - Costa d'Avorio 11
FI - Finlandia 10
JO - Giordania 10
EE - Estonia 7
UA - Ucraina 7
ZA - Sudafrica 7
HK - Hong Kong 6
NG - Nigeria 6
BE - Belgio 5
ID - Indonesia 5
AT - Austria 4
NL - Olanda 4
CA - Canada 2
CD - Congo 2
TW - Taiwan 2
CZ - Repubblica Ceca 1
GR - Grecia 1
LT - Lituania 1
PA - Panama 1
UZ - Uzbekistan 1
Totale 1.794
Città #
Bologna 96
Singapore 86
Chandler 85
Santa Clara 70
Fairfield 68
Southend 67
Ashburn 57
Houston 45
Woodbridge 44
Dublin 39
Seattle 37
Dong Ket 34
Wilmington 29
Princeton 28
Lomé 27
Boardman 24
Cambridge 23
Beijing 21
Florence 21
Sofia 18
Vicenza 18
Bern 15
Turin 13
Milan 12
Abidjan 11
Amman 10
Shanghai 10
Helsinki 9
Redmond 9
Berlin 8
Bremen 8
Jinan 8
New York 8
Westminster 8
Ann Arbor 7
Forlì 7
Nanjing 7
Abeokuta 6
Los Angeles 6
Tianjin 6
Brussels 5
Hebei 5
Jakarta 5
San Diego 5
Shenyang 5
Boydton 4
Falls Church 4
Rome 4
Bühl 3
Carpi 3
Changsha 3
Fuzhou 3
Hangzhou 3
Hong Kong 3
Medford 3
Naples 3
Nuremberg 3
Padova 3
Paris 3
Redwood City 3
Vienna 3
Amsterdam 2
Arzano 2
Cesena 2
Dearborn 2
Des Moines 2
Formigine 2
Groningen 2
Guangzhou 2
Imola 2
Ithaca 2
Kilburn 2
Kinshasa 2
Messina 2
Modena 2
Montelupone 2
Mülheim 2
Palermo 2
Pescara 2
Prescot 2
Pune 2
Rimini 2
Shijiazhuang 2
Taipei 2
Wuhan 2
Xiamen 2
Bassano Del Grappa 1
Bedford 1
Casalecchio di Reno 1
Castel San Pietro Terme 1
Castenaso 1
Castiglione dei Pepoli 1
Changzhou 1
Chengdu 1
Clearwater 1
Cogollo del Cengio 1
Costa Mesa 1
Cotignola 1
Falkenstein 1
Ferrara 1
Totale 1.245
Nome #
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding 149
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. 145
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 139
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 127
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 125
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 125
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 122
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history 117
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience 99
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 95
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 91
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 84
Expected and non-expected immune-related adverse events detectable by CT 74
Emerging therapies in malignant pleural mesothelioma 68
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 65
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 60
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 60
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift? 56
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 48
The safety and efficacy of enzalutamide in the treatment of advanced prostate cancer 30
Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need? 14
Totale 1.893
Categoria #
all - tutte 5.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 0 0 34 40 13 17 15
2020/2021241 23 25 25 0 26 6 12 8 13 9 15 79
2021/2022221 7 2 7 4 17 16 5 27 16 19 60 41
2022/2023537 21 54 12 56 49 68 30 35 88 13 66 45
2023/2024182 16 22 15 15 19 40 5 6 10 21 6 7
2024/2025413 12 78 51 47 102 48 67 8 0 0 0 0
Totale 1.893